Home Biocept Inc

Biocept Inc

Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection

Senior Vice President and Medical Director of Biocept Veena Singh, M.D. said, "The ability to detect PR expression in circulating tumor cells (CTCs) complements Biocept's existing ER and HER2 assays for biomarker analysis in breast cancer."